Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2023年8月31日
	新闻
	Encorafenib/Binimetinib Combo Highlights Novel Therapies for BRAF V600+ NSCLC OncLive Novel combinations are in development for the treatment of patients with BRAF V600-muated non–small cell lung cancer (NSCLC), and although ... 标记为不相关
	Global NSCLC Market Propelled by 11.6% CAGR Growth: Battling Lung Cancer's Impact ... PR Newswire NSCLC constitutes a group of lung cancers, encompassing subtypes like squamous cell carcinoma and adenocarcinoma. Treatment options for NSCLC include ... 标记为不相关
	How Is Administrative Payment Burden Associated With Cost-Related Delays in Cancer Care The ASCO Post Half of the participant population was selected from patients or survivors who had breast, colorectal, lung, or prostate cancers; the other half ... 标记为不相关
	City of Hope is First to Offer a Novel Precision Medicine Technology in Southern California Targeted Oncology RefleXion receives breakthrough device designation for lung cancer treatment. News release. RefleXion Medical, Inc. December 1, 2021. 标记为不相关
	Court rules in favor of St. Peter's Health in Weiner termination - KTVH KTVH However, upon review, the patient was determined not to have lung cancer and "died as a result of said chemotherapy." Weiner denied the allegations in ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈